InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by RENSCHLER MARKUS MD. Director active across 1 company, notably Cyteir Therapeutics, Inc.. In total, 5 disclosures have been logged. History available since 21 December 2022. The latest transaction was filed on 29 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations